205 related articles for article (PubMed ID: 36072980)
1. The Regulatory Role of Lipid Metabolism in Endometrial Cancer.
Zhang S; Han X
J Oncol; 2022; 2022():6458877. PubMed ID: 36072980
[TBL] [Abstract][Full Text] [Related]
2. Etiological relationship between lipid metabolism and endometrial carcinoma.
Li W; Xu Y; Zeng X; Tan J; Wang Y; Wu H; Li M; Yi C
Lipids Health Dis; 2023 Aug; 22(1):116. PubMed ID: 37537560
[TBL] [Abstract][Full Text] [Related]
3. Endometrial Cancer: Genetic, Metabolic Characteristics, Therapeutic Strategies and Nanomedicine.
Cai Y; Wang B; Xu W; Liu K; Gao Y; Guo C; Chen J; Kamal MA; Yuan C
Curr Med Chem; 2021; 28(42):8755-8781. PubMed ID: 34225603
[TBL] [Abstract][Full Text] [Related]
4. Small molecule targeted therapies for endometrial cancer: progress, challenges, and opportunities.
Yang FF; Zhao TT; Milaneh S; Zhang C; Xiang DJ; Wang WL
RSC Med Chem; 2024 Jun; 15(6):1828-1848. PubMed ID: 38911148
[TBL] [Abstract][Full Text] [Related]
5. The Role of Metabolic Syndrome in Endometrial Cancer: A Review.
Yang X; Wang J
Front Oncol; 2019; 9():744. PubMed ID: 31440472
[TBL] [Abstract][Full Text] [Related]
6. The Role of Hyperglycemia in Endometrial Cancer Pathogenesis.
Byrne FL; Martin AR; Kosasih M; Caruana BT; Farrell R
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397158
[TBL] [Abstract][Full Text] [Related]
7. Lipid metabolism analysis in esophageal cancer and associated drug discovery.
Jiao R; Jiang W; Xu K; Luo Q; Wang L; Zhao C
J Pharm Anal; 2024 Jan; 14(1):1-15. PubMed ID: 38352954
[TBL] [Abstract][Full Text] [Related]
8. The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC.
Qi X; Li Q; Che X; Wang Q; Wu G
Front Oncol; 2021; 11():727778. PubMed ID: 34604067
[TBL] [Abstract][Full Text] [Related]
9. A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value.
Li D; Liang J; Yang W; Guo W; Song W; Zhang W; Wu X; He B
Front Oncol; 2022; 12():876981. PubMed ID: 35957912
[TBL] [Abstract][Full Text] [Related]
10. Autophagy Machinery as a Promising Therapeutic Target in Endometrial Cancer.
Nuñez-Olvera SI; Gallardo-Rincón D; Puente-Rivera J; Salinas-Vera YM; Marchat LA; Morales-Villegas R; López-Camarillo C
Front Oncol; 2019; 9():1326. PubMed ID: 31850214
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer.
Yi R; Xie L; Wang X; Shen C; Chen X; Qiao L
Front Oncol; 2022; 12():861142. PubMed ID: 35574395
[TBL] [Abstract][Full Text] [Related]
12. Lipid metabolism as a target for cancer drug resistance: progress and prospects.
Wang Z; Wang Y; Li Z; Xue W; Hu S; Kong X
Front Pharmacol; 2023; 14():1274335. PubMed ID: 37841917
[TBL] [Abstract][Full Text] [Related]
13. Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer.
Dai M; Yang B; Chen J; Liu F; Zhou Y; Zhou Y; Xu Q; Jiang S; Zhao S; Li X; Zhou X; Yang Q; Li J; Wang Y; Zhang Z; Teng Y
Cancer Lett; 2021 Aug; 513():36-49. PubMed ID: 33991616
[TBL] [Abstract][Full Text] [Related]
14. Lipid Metabolism and Cancer.
Cheng H; Wang M; Su J; Li Y; Long J; Chu J; Wan X; Cao Y; Li Q
Life (Basel); 2022 May; 12(6):. PubMed ID: 35743814
[TBL] [Abstract][Full Text] [Related]
15. Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism.
Yao L; Chen S; Li W
Arch Biochem Biophys; 2020 May; 684():108327. PubMed ID: 32142890
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolism in tumor microenvironment: novel therapeutic targets.
Liu X; Zhang P; Xu J; Lv G; Li Y
Cancer Cell Int; 2022 Jul; 22(1):224. PubMed ID: 35790992
[TBL] [Abstract][Full Text] [Related]
17. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
[TBL] [Abstract][Full Text] [Related]
18. Lipid metabolism in cancer progression and therapeutic strategies.
Fu Y; Zou T; Shen X; Nelson PJ; Li J; Wu C; Yang J; Zheng Y; Bruns C; Zhao Y; Qin L; Dong Q
MedComm (2020); 2021 Mar; 2(1):27-59. PubMed ID: 34766135
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.
Li W; Wang S; Qiu C; Liu Z; Zhou Q; Kong D; Ma X; Jiang J
J Transl Med; 2019 Feb; 17(1):58. PubMed ID: 30813939
[TBL] [Abstract][Full Text] [Related]
20. Current status of molecular-targeted drugs for endometrial cancer (Review).
Nogami Y; Banno K; Kisu I; Yanokura M; Umene K; Masuda K; Kobayashi Y; Yamagami W; Nomura H; Tominaga E; Susumu N; Aoki D
Mol Clin Oncol; 2013 Sep; 1(5):799-804. PubMed ID: 24649249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
